1

Appendix 5: Draft Detailed Risk Modeling Results 

   
2

Table 1 - Facility Identification Information 

Source 

Category Facility NEI ID Facility Name Address City State 

Secondary Lead NEI117 

EAST PENN MFG CO 

INC/SMELTER PLT DEKA RD PO BOX 147 LYON STATION PA 

Secondary Lead NEI18383 SANDERS LEAD CO 100 SANDERS RD TROY AL 

Secondary Lead NEI21201 QUEMETCO INC 720 S 7TH AV INDUSTRY CA 

Secondary Lead NEI26338 GULF COAST RECYCLING, INC. 1901 N 66TH STREET TAMPA FL 

Secondary Lead NEI2CA124838 EXIDE CORPORATION 

2700 SOUTH INDIANA 

STREET VERNON CA 

Secondary Lead NEI31400 EXIDE TECHNOLOGIES 

2601 WEST MT 

PLEASANT BLVD MUNCIE IN 

Secondary Lead NEI32182 QUEMETCO, INC. 

7870 W. MORRIS 

STREET INDIANAPOLIS IN 

Secondary Lead NEI34021 GOPHER RESOURCE CORP 3385 S HIGHWAY 149 EAGAN MN 

Secondary Lead NEI34270 

EXIDE TECHNOLOGIES-CANON 

HOLLOW PLANT 

111 CANON HOLLOW 

ROAD FOREST CITY MO 

Secondary Lead NEI38394 

REVERE SMELTING & REFINING 

CORP 65 BALLARD RD MIDDLETOWN NY 

Secondary Lead NEI40662 EXIDE TECH/READING SMELTER 

2ND & WASHINGTON 

ST READING PA 

Secondary Lead NEI6493 FRISCO BATTERY RECYCLING 7471 S FIFTH ST FRISCO TX 

Secondary Lead NEILAT$10672 

EXIDE TECHNOLOGIES/B R 

SMELTER 2400 BROOKLAWN DR BATON ROUGE LA 

Secondary Lead NEIMO0930005 DOE RUN COMPANY-BUICK MILL HIGHWAY KK BOSS MO 

   
3

Table 2 – Maximum Predicted HEM-3 Chronic Risks 

Facility NEI ID 

 Source Category Chronic Risk 1

Cancer 

MIR 

Cancer 

 Incidence 

Noncancer 

Max HI 

Target 

Organ 

Baseline scenario 

NEI117 7.63E-06 1.76E-04 9.03E-02 developmental 

NEI18383 4.42E-05 7.21E-04 5.37E-01 kidney 

NEI21201 5.95E-06 1.34E-03 7.54E-02 kidney 

NEI26338 1.24E-05 1.95E-03 1.32E-01 kidney 

NEI2CA124838 7.69E-06 8.13E-03 9.58E-02 kidney 

NEI31400 2.00E-06 1.52E-04 2.43E-02 developmental 

NEI32182 2.00E-06 8.28E-04 2.89E-02 developmental 

NEI34021 1.52E-05 7.06E-04 1.92E-01 kidney 

NEI34270 4.72E-06 2.70E-05 6.66E-02 respiratory 

NEI38394 7.57E-06 4.48E-04 1.06E-01 developmental 

NEI40662 4.79E-05 1.16E-03 5.89E-01 developmental 

NEI6493 4.45E-05 1.73E-03 5.00E-01 developmental 

NEILAT$10672 1.33E-06 6.33E-04 1.63E-02 respiratory 

NEIMO0930005 3.93E-05 8.20E-04 4.78E-01 developmental 

Control Scenario 

NEI117 2.01E-06 7.00E-05 2.50E-02 developmental 

NEI18383 4.54E-06 1.98E-04 1.19E-01 respiratory 

NEI21201 5.95E-06 1.34E-03 7.54E-02 kidney 

NEI26338 2.73E-06 1.32E-03 5.68E-02 respiratory 

NEI2CA124838 3.20E-06 4.23E-03 3.85E-02 kidney 

NEI31400 7.12E-07 7.95E-05 9.40E-03 developmental 

NEI32182 1.93E-06 8.13E-04 2.81E-02 developmental 

NEI34021 3.17E-06 2.85E-04 3.86E-02 kidney 

NEI34270 1.78E-06 1.85E-05 6.16E-02 respiratory 

NEI38394 7.37E-06 4.43E-04 1.04E-01 developmental 

NEI40662 1.24E-05 4.92E-04 1.76E-01 developmental 

NEI6493 8.68E-06 1.01E-03 1.42E-01 respiratory 

NEILAT$106722 6.94E-07 4.35E-04 1.52E-02 respiratory 

NEIMO09300052 8.57E-06 4.51E-04 1.20E-01 developmental 

1

 BOLD indicates cancer risk greater than 1 in a million or noncancer risk greater than 1 

2

 Results presented for the control scenario do not reflect additional reductions in risk expected from stack 

emission limits that would affect this facility 

   
4

Table 3 – Maximum Predicted Acute Risks by Facility 

Facility NEI ID Pollutant Criteria

HEM-3 

(Screening) 

(Baseline) 

HEM-3 

(Screening) 

(Controlled) 

Refined 

Results 1 

(Controlled) 

NEI117 Arsenic compounds REL 0.6 0.4 

NEI18383 Arsenic compounds REL 4.5 0.5 

NEI21201 Arsenic compounds REL 0.5 0.5 

NEI26338 Arsenic compounds REL 0.8 0.3 

NEI2CA124838 Arsenic compounds REL 2.4 1.1 

NEI31400 Arsenic compounds REL 1.0 0.4 

NEI32182 Arsenic compounds REL 1.2 1.2 

NEI34021 Arsenic compounds REL 1.6 0.4 

NEI34270 Arsenic compounds REL 3.4 0.3 

NEI38394 Arsenic compounds REL 5.5 5.4 4.8

NEI40662 Arsenic compounds REL 1.7 1.2 

NEI6493 Arsenic compounds REL 3.9 0.9 

NEILAT$106722 Arsenic compounds REL 30.0 2.9 0.6

NEIMO09300052 Arsenic compounds REL 19.8 1.4 

1 Facilities with a HEM-3 screening controlled value greater than 1 were refined by examining results for 

maximum off-site impacts, see Appendix 6 for figures depicting off-site impacts 

2 Screening controlled results also reflect reductions in risk expected from stack emission limits that would 

affect this facility 

 
5

Table 4 – Maximum Predicted Lead Risks by Facility

Facility NEI ID 

Concentration 

is X times 

higher than 

the NAAQS 

(Baseline) 

Concentration 

is X times 

higher than 

the NAAQS 

(Controlled) 

NEI117 0.7 0.1

NEI18383 19 1

NEI21201 1.5 1.5

NEI26338 5 0.4

NEI2CA124838 10 4.3

NEI31400 1.3 0.3

NEI32182 0.6 0.5

NEI34021 3 0.7

NEI34270 4 0.3

NEI38394 1.4 1.1

NEI40662 4 0.5

NEI6493 3 0.4

NEILAT$106721 6 3.92

NEIMO09300051 23 1.5

1

 Screening controlled results do not include reductions in risk expected from emission limits on stacks 

that would affect this facility. 

2

 Considering reductions in stack emissions, estimated modeled ambient lead concentrations resulting 

from NEILAT$10672 are less than the NAAQS for lead.